UPDATE : Tuesday, August 4, 2020
Samsung Biologics signs CDO contract with PharmAbcine
Samsung Biologics said Monday that it has signed a contract developing orga...
by Shim Hyun-tai  |  2020-04-06 18:00
AbClon draws many new human antibodies to fight COVID-19
AbClon, a company specializing in developing antibodies, said Monday that i...
by Shim Hyun-tai  |  2020-03-30 17:47
ImmuneMed under fire for inflating drug’s effect against COVID-19
ImmuneMed, a local biotech firm, has come under criticism for exaggerating ...
by Jeong Sae-im  |  2020-03-27 11:49
Warrant sought to arrest Medytox CEO for illegally making, selling Meditoxin
Prosecutors have requested a court to issue an arrest warrant for Medytox C...
by Jeong Sae-im  |  2020-03-25 14:09
Will next-generation COVID-19 tests replace standard PCR checks?
Biotech companies are chasing new diagnostics to detect the new coronavirus...
by Jeong Sae-im  |  2020-03-25 11:40
KoBioLabs' allergic immune disease treatment enters global clinical trial
KoBioLabs, a company specializing in the microbiome, said Monday that it ha...
by Shim Hyun-tai  |  2020-03-23 16:03
Samsung Bioepis’ biosimilar breast cancer treatment scores FDA’s nod
Samsung Bioepis said Friday that the U.S. Food and Drug Administration has ...
by Lee Han-soo  |  2020-03-20 16:52
Samsung Biologics makes CDO partnership with Taiwanese bio-venture
Samsung Biologics said that it has entered into a contract developing organ...
by Lee Han-soo  |  2020-03-17 17:31
Celltrion Healthcare launches anticancer biosimilar Herzuma in US
Celltrion Healthcare said Tuesday that the company has launched its antican...
by Lee Han-soo  |  2020-03-17 16:21
‘Celltrion to invest ₩20 billion to develop COVID-19 cure in 6 months’
Celltrion said that it would start clinical trials on humans to come up wit...
by Lee Han-soo  |  2020-03-13 17:38
SK Bioscience threatens MSD's sway over shingles vaccine market
SK Bioscience's shingles vaccine Skyzoster, launched only two years ago...
by Lee Han-soo  |  2020-03-12 17:05
Bridge Biotherapeutics, Atomwise to develop new drugs using AI
Bridge Biotherapeutics said that it would partner up with Atomwise, a U.S. ...
by Lee Han-soo  |  2020-03-10 12:26
Celltrion applies for approval of new Humira biosimilar to EMA
Celltrion said Monday that it has completed the application of its CT-P17, ...
by Shim Hyun-tai  |  2020-03-09 16:40
Celltrion Healthcare’s 2019 sales top ₩1 trillion
Celltrion Healthcare said that it registered 1 trillion won ($840.6 million...
by Lee Han-soo  |  2020-03-06 17:31
Samsung BioLogics, STCube to develop immunotherapies
Samsung BioLogics said that it has signed a contract development organizati...
by Lee Han-soo  |  2020-03-03 16:18
Celltrion Healthcare presents Remsima SC in UK
Celltrion Healthcare, the distribution and marketing unit of Korea's bi...
by Lee Han-soo  |  2020-03-02 17:42
HLB seeks new pipelines by taking over US biotech firm
HLB, a Kosdaq-listed firm, said it would seek to secure new pipelines other...
by Jeong Sae-im  |  2020-02-21 15:42
Celltrion’s annual revenue surpassed ₩1 trillion in 2019
Celltrion, the nation’s leading biosimilar manufacturer, said its annual sa...
by Jeong Sae-im  |  2020-02-20 15:47
Prescription of Celltrion’s Remsima SC started in Germany
Celltrion Healthcare, the distribution and marketing unit of Korea’s biosim...
by Jeong Sae-im  |  2020-02-18 16:05
Korea University analyzes 5,000 cancer patients’ genomic data 
Korea University’s state-supported precision medicine project group, dubbed...
by Kim Yun-mi  |  2020-02-11 15:49
Back to Top